These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 8389616
1. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): predominance of type A virus associated with Hodgkin's disease. Lin JC, Lin SC, De BK, Chan WP, Evatt BL, Chan WC. Blood; 1993 Jun 15; 81(12):3372-81. PubMed ID: 8389616 [Abstract] [Full Text] [Related]
2. A strategy for precision of genotyping of Epstein-Barr virus by polymerase chain reaction: application for studying Hodgkin's lymphoma. Lin JC, Lin SC, Mar EC. Leuk Lymphoma; 1994 Nov 15; 15(5-6):389-97. PubMed ID: 7873996 [Abstract] [Full Text] [Related]
3. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Dirnhofer S, Angeles-Angeles A, Ortiz-Hidalgo C, Reyes E, Gredler E, Krugmann J, Fend F, Quintanilla-Martinez L. Hum Pathol; 1999 Jul 15; 30(7):781-7. PubMed ID: 10414496 [Abstract] [Full Text] [Related]
4. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS. J Exp Med; 1993 Feb 01; 177(2):339-49. PubMed ID: 8381153 [Abstract] [Full Text] [Related]
5. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Preciado MV, De Matteo E, Diez B, Menárguez J, Grinstein S. Blood; 1995 Nov 15; 86(10):3922-9. PubMed ID: 7579362 [Abstract] [Full Text] [Related]
6. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM. Blood; 1995 Mar 01; 85(5):1396-403. PubMed ID: 7858270 [Abstract] [Full Text] [Related]
7. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease. Brousset P, Meggetto F, Chittal S, Bibeau F, Arnaud J, Rubin B, Delsol G. Lab Invest; 1993 Oct 01; 69(4):483-90. PubMed ID: 8231115 [Abstract] [Full Text] [Related]
8. Rapid and sensitive genotyping of Epstein-Barr virus using single-strand conformation polymorphism analysis of polymerase chain reaction products. Lin JC, De BK, Lin SC. J Virol Methods; 1993 Jul 01; 43(2):233-46. PubMed ID: 8396156 [Abstract] [Full Text] [Related]
9. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. J Virol; 1990 Sep 01; 64(9):4084-92. PubMed ID: 2166806 [Abstract] [Full Text] [Related]
11. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N. J Virol; 1994 Dec 01; 68(12):7918-26. PubMed ID: 7966582 [Abstract] [Full Text] [Related]
12. Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma. Fassone L, Cingolani A, Martini M, Migliaretti G, Oreste PL, Capello D, Gloghini A, Vivenza D, Dolcetti R, Carbone A, Antinori A, Gaidano G, Larocca LM. AIDS Res Hum Retroviruses; 2002 Jan 01; 18(1):19-26. PubMed ID: 11804553 [Abstract] [Full Text] [Related]
13. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Weinreb M, Day PJ, Niggli F, Green EK, Nyong'o AO, Othieno-Abinya NA, Riyat MS, Raafat F, Mann JR. Blood; 1996 May 01; 87(9):3828-36. PubMed ID: 8611709 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E. J Virol; 1995 May 01; 69(5):3108-16. PubMed ID: 7707539 [Abstract] [Full Text] [Related]
16. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM. J Gen Virol; 1994 Feb 01; 75 ( Pt 2)():431-7. PubMed ID: 8113767 [Abstract] [Full Text] [Related]
17. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Lancet; 1991 Feb 09; 337(8737):320-2. PubMed ID: 1671232 [Abstract] [Full Text] [Related]
19. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency. Kanavaros P, Jiwa M, van der Valk P, Walboomers J, Horstman A, Meijer CJ. Hum Pathol; 1993 Jul 09; 24(7):725-9. PubMed ID: 8100553 [Abstract] [Full Text] [Related]
20. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. Jiang H, Cho YG, Wang F. J Virol; 2000 Jul 09; 74(13):5921-32. PubMed ID: 10846073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]